Cardiac Marker Analyzer – Worldwide Analysis
Point of Care Testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. This diagnostic platform that helps physicians identifies several critical health conditions, including heart failure and myocardial infarction and reduces the time to diagnosis by hours.
This 62 page report contains 3 Figures and 14 Tables provides a comprehensive analysis of the emerging cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger and acquisitions, distribution agreement, collaboration deals and companies analyzer sales figures.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Analyzer Benefits and Features
2. Net Product Sales
3. Merger & Acquisition
4. Distribution Agreement
5. Collaboration Deal
6. Licensing (Exclusive) Agreement
All the 12 Cardiac Marker Analyzer studied in the report are as follows
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. Cobas H 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
This 62 page report contains 3 Figures and 14 Tables provides a comprehensive analysis of the emerging cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger and acquisitions, distribution agreement, collaboration deals and companies analyzer sales figures.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Analyzer Benefits and Features
2. Net Product Sales
3. Merger & Acquisition
4. Distribution Agreement
5. Collaboration Deal
6. Licensing (Exclusive) Agreement
All the 12 Cardiac Marker Analyzer studied in the report are as follows
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. Cobas H 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. CARDIAC MARKER COMPANIES – COMPARATIVE TESTS ANALYSIS
3. CARDIAC MARKER ANALYZER – COMPETITIVE PRODUCT ANALYSIS
4. CARDIAC MARKER ANALYZERS OR CARDIAC READER SYSTEM
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Inc Merger & Acquisition in Cardiac Marker Devices Market
4.3 Alere Inc Distribution Agreement in Cardiac Marker Devices Market
4.4 Alere Cardiology Net Product Sales
5. RESPONSE BIOMEDICAL
5.1 RAMP Platform
5.1.1 RAMP
5.1.2 RAMP Reader
5.2 Response Biomedical Cardiovascular Net Product Sales
5.3 Response Biomedical Distribution Agreement in Cardiac Marker Devices Market
5.4 Response Biomedical Collaboration Deal in Cardiac Marker Devices Market
6. ABBOTT POINT OF CARE
6.1 The i–STAT System
6.2 Abbott Laboratories Point of Care Diagnostics Sales
6.3 Abbott Laboratories Merger & Acquisition in Cardiac Markers Devices Market
7. ROCHE
7.1 Cobas H 232 POC System
8. SIEMEN HEALTHCARE
8.1 Stratus CS Analyzer
9. BECKMAN COULTER
9.1 Access 2 Immunoassay System
10. BODITECH
10.1 i–chroma DUO Analyzer
11. LIFESIGN
11.1 DXpress Reader Analyzer
12. MITSUBISHI CHEMICAL MEDIENCE CORPORATION
12.1 PATHFAST Analyzer
12.2 Mitsubishi Chemical Medience Corporation Licensing (Exclusive) Agreement in Cardiac Markers Devices Market
13. TRINITY BIOTECH
13.1 Meritas POC Analyzer
13.2 Trinity Biotech Merger & Acquisition in Cardiac Marker Devices Market
14. CARDIOGENICS
14.1 QL Care Analyzer
14.2 CardioGenics Licensing (Manufacturing) Agreement in Cardiac Markers Devices Market
15. EMERGING MARKERS
2. CARDIAC MARKER COMPANIES – COMPARATIVE TESTS ANALYSIS
3. CARDIAC MARKER ANALYZER – COMPETITIVE PRODUCT ANALYSIS
4. CARDIAC MARKER ANALYZERS OR CARDIAC READER SYSTEM
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Inc Merger & Acquisition in Cardiac Marker Devices Market
4.3 Alere Inc Distribution Agreement in Cardiac Marker Devices Market
4.4 Alere Cardiology Net Product Sales
5. RESPONSE BIOMEDICAL
5.1 RAMP Platform
5.1.1 RAMP
5.1.2 RAMP Reader
5.2 Response Biomedical Cardiovascular Net Product Sales
5.3 Response Biomedical Distribution Agreement in Cardiac Marker Devices Market
5.4 Response Biomedical Collaboration Deal in Cardiac Marker Devices Market
6. ABBOTT POINT OF CARE
6.1 The i–STAT System
6.2 Abbott Laboratories Point of Care Diagnostics Sales
6.3 Abbott Laboratories Merger & Acquisition in Cardiac Markers Devices Market
7. ROCHE
7.1 Cobas H 232 POC System
8. SIEMEN HEALTHCARE
8.1 Stratus CS Analyzer
9. BECKMAN COULTER
9.1 Access 2 Immunoassay System
10. BODITECH
10.1 i–chroma DUO Analyzer
11. LIFESIGN
11.1 DXpress Reader Analyzer
12. MITSUBISHI CHEMICAL MEDIENCE CORPORATION
12.1 PATHFAST Analyzer
12.2 Mitsubishi Chemical Medience Corporation Licensing (Exclusive) Agreement in Cardiac Markers Devices Market
13. TRINITY BIOTECH
13.1 Meritas POC Analyzer
13.2 Trinity Biotech Merger & Acquisition in Cardiac Marker Devices Market
14. CARDIOGENICS
14.1 QL Care Analyzer
14.2 CardioGenics Licensing (Manufacturing) Agreement in Cardiac Markers Devices Market
15. EMERGING MARKERS
LIST OF TABLES:
Table 2 1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 3: Cardiac Marker Companies – Comparative Tests Analysis
Table 3 1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3 2: Cardiac Marker Analyzer – Competitive Product Analysis
Table 4 1: Alere – Merger & Acquisition, 2007, 2009
Table 4 2: Alere – Distribution Agreement, 2008
Table 5 1: Response Biomedical – Distribution Agreement, 2011–2013
Table 5 2: Response Biomedical – Collaboration Deal, 2004
Table 6 1: Abbott Laboratories – Merger & Acquisition, 2003
Table 12 1: PATHFAST – Technical Specifications
Table 12 2: Mitsubishi Chemical Medience Corporation – Licensing Agreement, 2011
Table 13 1: Trinity Biotech – Merger & Acquisition, 2012
Table 14 1: Cardiogenics – Licensing Agreement, 2012
Table 2 1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 3: Cardiac Marker Companies – Comparative Tests Analysis
Table 3 1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3 2: Cardiac Marker Analyzer – Competitive Product Analysis
Table 4 1: Alere – Merger & Acquisition, 2007, 2009
Table 4 2: Alere – Distribution Agreement, 2008
Table 5 1: Response Biomedical – Distribution Agreement, 2011–2013
Table 5 2: Response Biomedical – Collaboration Deal, 2004
Table 6 1: Abbott Laboratories – Merger & Acquisition, 2003
Table 12 1: PATHFAST – Technical Specifications
Table 12 2: Mitsubishi Chemical Medience Corporation – Licensing Agreement, 2011
Table 13 1: Trinity Biotech – Merger & Acquisition, 2012
Table 14 1: Cardiogenics – Licensing Agreement, 2012
LIST OF FIGURES:
Figure 4–1: Worldwide – Alere Cardiology Net Product Sales (Million US$), 2010 – 2013
Figure 5–1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2010 – 2013
Figure 6–1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2013
Figure 4–1: Worldwide – Alere Cardiology Net Product Sales (Million US$), 2010 – 2013
Figure 5–1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2010 – 2013
Figure 6–1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2013
